scholarly journals Segmental and total uniparental isodisomy (UPiD) as a disease mechanism in autosomal recessive lysosomal disorders: evidence from SNP arrays

2019 ◽  
Vol 27 (6) ◽  
pp. 919-927 ◽  
Author(s):  
Ineke Labrijn-Marks ◽  
Galhana M. Somers-Bolman ◽  
Stijn L. M. In ’t Groen ◽  
Marianne Hoogeveen-Westerveld ◽  
Marian A. Kroos ◽  
...  
Author(s):  
Bart Appelhof ◽  
Matias Wagner ◽  
Julia Hoefele ◽  
Anja Heinze ◽  
Timo Roser ◽  
...  

Abstract Pontocerebellar hypoplasia (PCH) describes a group of rare heterogeneous neurodegenerative diseases with prenatal onset. Here we describe eight children with PCH from four unrelated families harboring the homozygous MINPP1 (NM_004897.4) variants; c.75_94del, p.(Leu27Argfs*39), c.851 C > A, p.(Ala284Asp), c.1210 C > T, p.(Arg404*), and c.992 T > G, p.(Ile331Ser). The homozygous p.(Leu27Argfs*39) change is predicted to result in a complete absence of MINPP1. The p.(Arg404*) would likely lead to a nonsense mediated decay, or alternatively, a loss of several secondary structure elements impairing protein folding. The missense p.(Ala284Asp) affects a buried, hydrophobic residue within the globular domain. The introduction of aspartic acid is energetically highly unfavorable and therefore predicted to cause a significant reduction in protein stability. The missense p.(Ile331Ser) affects the tight hydrophobic interactions of the isoleucine by the disruption of the polar side chain of serine, destabilizing the structure of MINPP1. The overlap of the above-mentioned genotypes and phenotypes is highly improbable by chance. MINPP1 is the only enzyme that hydrolyses inositol phosphates in the endoplasmic reticulum lumen and several studies support its role in stress induced apoptosis. The pathomechanism explaining the disease mechanism remains unknown, however several others genes of the inositol phosphatase metabolism (e.g., INPP5K, FIG4, INPP5E, ITPR1) are correlated with phenotypes of neurodevelopmental disorders. Taken together, we present MINPP1 as a novel autosomal recessive pontocerebellar hypoplasia gene.


2014 ◽  
Vol 23 (5) ◽  
pp. 734-741 ◽  
Author(s):  
Jessica E. King ◽  
Amy Dexter ◽  
Inder Gadi ◽  
Val Zvereff ◽  
Meaghan Martin ◽  
...  

2012 ◽  
Vol 15 (5) ◽  
pp. 354-360 ◽  
Author(s):  
Klaas J. Wierenga ◽  
Zhijie Jiang ◽  
Amy C. Yang ◽  
John J. Mulvihill ◽  
Nicholas F. Tsinoremas

2017 ◽  
Vol 92 (5) ◽  
pp. 1130-1144 ◽  
Author(s):  
Patricia Outeda ◽  
Luis Menezes ◽  
Erum A. Hartung ◽  
Stacey Bridges ◽  
Fang Zhou ◽  
...  

2018 ◽  
Vol 154 (3) ◽  
pp. 137-146 ◽  
Author(s):  
Yo Niida ◽  
Mamoru Ozaki ◽  
Masaki Shimizu ◽  
Kazuyuki Ueno ◽  
Tomomi Tanaka

Patients with autosomal recessive (AR) disorders are usually born to parents both of whom are heterozygous carriers of the disease. However, in some instances only one of the parents is a carrier and a mutation is segregated to the patient through uniparental isodisomy (UPiD). Recently, an increasing number of such case reports has been published, and it has become clear that there are several different UPiD patterns that cause AR disorders. In this article, we report 3 remarkable patients with different patterns of UPiD. We then review 85 cases collected in the literature. We realized that they can be classified into 3 patterns: UPiD of the whole chromosome, segmental UPiD with uniparental heterodisomy (UPhD), and segmental UPiD caused by post-zygotic mitotic recombination (MiRe). Whole chromosomal UPiD accounted for the majority of cases, with paternal origin accounting for approximately twice as many cases as maternal origin. Most cases of segmental UPiD with UPhD were of maternal origin, with a dominancy of nondisjunction in meiosis I, while segmental UPiD through MiRe is the smallest pattern with equal parental origin. These differences in proportion and parental origin in each pattern can be explained by considering nondisjunction during oogenesis as the starting point and UPiD as subsequent events.


2014 ◽  
Vol 88 (3) ◽  
pp. 261-266 ◽  
Author(s):  
Y. Ohtsuka ◽  
K. Higashimoto ◽  
K. Sasaki ◽  
K. Jozaki ◽  
H. Yoshinaga ◽  
...  

2007 ◽  
Vol 18 (5) ◽  
pp. 1683-1692 ◽  
Author(s):  
Joanna C. Bakowska ◽  
Henri Jupille ◽  
Parvin Fatheddin ◽  
Rosa Puertollano ◽  
Craig Blackstone

Troyer syndrome is an autosomal recessive hereditary spastic paraplegia caused by mutation in the spartin (SPG20) gene, which encodes a widely expressed protein of unknown function. This mutation results in premature protein truncation and thus might signify a loss-of-function disease mechanism. In this study, we have found that spartin is mono-ubiquitinated and functions in degradation of the epidermal growth factor receptor (EGFR). Upon EGF stimulation, spartin translocates from the cytoplasm to the plasma membrane and colocalizes with internalized EGF-Alexa. Knockdown of spartin by small interfering RNA decreases the rate of EGFR degradation and also affects EGFR internalization, recycling, or both. Furthermore, overexpression of spartin results in a prominent decrease in EGFR degradation. Taken together, our data suggest that spartin is involved in the intracellular trafficking of EGFR and that impaired endocytosis may underlie the pathogenesis of Troyer syndrome.


Sign in / Sign up

Export Citation Format

Share Document